BERLIN, March 10 (Xinhua) -- The founders of German vaccine maker BioNTech will step down to launch a new biotechnology company focused on next-generation mRNA medicines, the company said on Tuesday.
Ugur Sahin and Oezlem Tuereci will leave the Mainz-based company by the end of 2026 at the latest, when their current contracts expire. The couple plan to remain shareholders, retaining around 15 percent of BioNTech.
